Aug 22 |
Tectonic draws bullish view at Wells Fargo on lead asset
|
Aug 20 |
Tectonic Therapeutic to Participate in September Investor Conferences
|
Aug 14 |
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
|
Aug 5 |
Tectonic Therapeutic: Analyzing Its Post-Merger Valuation And Prospects
|
Jul 30 |
Tectonic gets FDA okay to begin clinical testing for lead drug TX45
|
Jul 30 |
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
|
Jul 19 |
Tectonic Therapeutic files to sell 2.97M shares of common stock for holders
|
Jun 21 |
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio
|
Jun 3 |
Tectonic Therapeutic appoints Daniel Lochner as CFO
|